The primary objective of this feasibility study is to assess the feasibility and acceptability, and potential clinical significance of an adaptive stepped-care intervention for improving sleep quality among Chinese cancer patients with mild-to-moderate sleep disturbance, using a sequential multiple assessment randomized controlled trial (SMART) design.
Conditions: Neoplasm, Sleep Disturbance
Eligibility Criteria
Inclusion Criteria
- Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynaecological cancer
- Completed treatment (except endocrine therapy) within two years
- Presenting with Pittsburgh Sleep Quality Index (PSQI) score of 6 to 11 indicating mild-to-moderate sleep disturbance
Exclusion Criteria
- Diagnosis of metastatic cancer
- Current diagnosis of psychiatric disorder
- Current diagnosis of another sleep disorder,
- Have received psychological treatment specifically for sleep disturbance
Eligibility criteria are kept as the original English records from ClinicalTrials.gov; actual eligibility is determined by the research team's formal assessment and the informed consent form. Source: ClinicalTrials.gov, updated automatically every two weeks. Last synced: 2026年10月8日.